Anti-SARS-CoV-2 IgG responses are powerful predicting signatures for the outcome of COVID-19 patients

INTRODUCTION: The COVID-19 global pandemic is far from ending. There is an urgent need to identify applicable biomarkers for early predicting the outcome of COVID-19. Growing evidences have revealed that SARS-CoV-2 specific antibodies evolved with disease progression and severity in COIVD-19 patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Lei, Qing, Yu, Cai-zheng, Li, Yang, Hou, Hong-yan, Xu, Zhao-wei, Yao, Zong-jie, Zhang, Yan-di, Lai, Dan-yun, Ndzouboukou, Jo-Lewis Banga, Zhang, Bo, Chen, Hong, Ouyang, Zhu-qing, Xue, Jun-biao, Lin, Xiao-song, Zheng, Yun-xiao, Wang, Xue-ning, Jiang, He-wei, Zhang, Hai-nan, Qi, Huan, Guo, Shu-juan, He, Mei-an, Sun, Zi-yong, Wang, Feng, Tao, Sheng-ce, Fan, Xiong-lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8641215/
https://www.ncbi.nlm.nih.gov/pubmed/35116173
http://dx.doi.org/10.1016/j.jare.2021.11.014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8641215/
https://www.ncbi.nlm.nih.gov/pubmed/35116173
http://dx.doi.org/10.1016/j.jare.2021.11.014

Ejemplares similares